The Minister added that the digital revolution in the world of work can also lead to occupational safety and health risks, for the prevention of which a digital work information system is being developed in Estonia, helping employees, employers and different agencies to prevent risks arising from the working environment by exchanging information between different databases.
In 2018 more than 100 000 new participants have joined the genome project. The state will allocate another 2.3 million euros for 2019 to enable at least 50 000 more people to join the Estonian Biobank. In the next phase of the project during the years 2019-2022 the plan is to integrate genetic data as a part of the everyday medical practice, to give people feedback about their personal genetic risks.
From today, January 21, it will be possible to buy prescription medicines from Estonian pharmacies with a digital prescription issued in Finland. Estonians will have the opportunity to buy prescription drugs outside Estonia by the end of 2019. Estonia and Finland will become the first two countries in Europe to exchange digital prescription data.
Estonia has started a program to recruit and genotype 100,000 new biobank participants as part of its National Personalized Medicine programme. Effort aims to develop personalized medicine in national healthcare.
The Estonian Government will allocate 5 million euros next year to a joint development project of the Ministry of Social Affairs, the National Institute for Health Development and the Estonian Genome Center of the University of Tartu. The project aims to collect the genetic data of 100 000 people and integrate it into everyday medical practice by giving people feedback of their personal genetic risks. The general purpose of the project is to boost the development of personalised medicine in Estonia.
Today, at the Cabinet Meeting, the Estonian Government approved the National HIV Action Plan for the years 2017-2025, developed in cooperation of the Ministry of Social Affairs and the National Institute for Health Development.
Today, 23 November, as part of the Estonian Presidency of the Council of the European Union, a high-level meeting in Brussels will focus on the new EU One Health Action Plan to tackle the spread of antimicrobial resistance (AMR) in the European Union and evidence-based policy making. The aim of the meeting is to support cooperation in the areas of health, agriculture and the environment in order to accelerate the implementation of intersectoral AMR actions at national, EU and global level.
Today and tomorrow, 30 and 31 October, the Estonian Presidency of the Council of the European Union will hold an international conference 'Cross-Border Aspects in Alcohol Policy – Tackling Harmful Use of Alcohol' in Tallinn.